Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 126511 entries
Sorted by: Best Match Show Resources per page
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.

Antioxidants (Basel, Switzerland)

Canta A, Chiorazzi A, Pozzi E, Fumagalli G, Monza L, Meregalli C, Carozzi VA, Rodriguez-Menendez V, Oggioni N, Näsström J, Marmiroli P, Cavaletti G.
PMID: 32645985
Antioxidants (Basel). 2020 Jul 07;9(7). doi: 10.3390/antiox9070594.

Oxaliplatin (OHP) is an antineoplastic compound able to induce peripheral neurotoxicity. Oxidative stress has been suggested to be a key factor in the development of OHP-related peripheral neurotoxicity. Mangafodipir, a contrast agent possessing mitochondrial superoxide dismutase (MnSOD)-mimetic activity, has...

Cite
Canta A, Chiorazzi A, Pozzi E, et al. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity. Antioxidants (Basel). 2020;9(7)doi: 10.3390/antiox9070594.
Canta, A., Chiorazzi, A., Pozzi, E., Fumagalli, G., Monza, L., Meregalli, C., Carozzi, V. A., Rodriguez-Menendez, V., Oggioni, N., Näsström, J., Marmiroli, P., & Cavaletti, G. (2020). Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity. Antioxidants (Basel, Switzerland), 9(7), . https://doi.org/10.3390/antiox9070594
Canta, Annalisa, et al. "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity." Antioxidants (Basel, Switzerland) vol. 9,7 (2020). doi: https://doi.org/10.3390/antiox9070594
Canta A, Chiorazzi A, Pozzi E, Fumagalli G, Monza L, Meregalli C, Carozzi VA, Rodriguez-Menendez V, Oggioni N, Näsström J, Marmiroli P, Cavaletti G. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity. Antioxidants (Basel). 2020 Jul 07;9(7). doi: 10.3390/antiox9070594. PMID: 32645985; PMCID: PMC7402145.
Copy Download .nbib Format: NLM
Permutation Tests for General Dependent Truncation.

Computational statistics & data analysis

Chiou SH, Qian J, Mormino E, Betensky RA.
PMID: 30613119
Comput Stat Data Anal. 2018 Dec;128:308-324. doi: 10.1016/j.csda.2018.07.012. Epub 2018 Jul 29.

Truncated survival data arise when the event time is observed only if it falls within a subject-specific region, known as the truncation set. Left-truncated data arise when there is delayed entry into a study, such that subjects are included...

Cite
Chiou SH, Qian J, Mormino E, et al. Permutation Tests for General Dependent Truncation. Comput Stat Data Anal. 2018;128:308-324doi: 10.1016/j.csda.2018.07.012.
Chiou, S. H., Qian, J., Mormino, E., Betensky, R. A. (2018). Permutation Tests for General Dependent Truncation. Computational statistics & data analysis, 128308-324. https://doi.org/10.1016/j.csda.2018.07.012
Chiou, Sy Han, et al. "Permutation Tests for General Dependent Truncation." Computational statistics & data analysis vol. 128 (2018): 308-324. doi: https://doi.org/10.1016/j.csda.2018.07.012
Chiou SH, Qian J, Mormino E, Betensky RA. Permutation Tests for General Dependent Truncation. Comput Stat Data Anal. 2018 Dec;128:308-324. doi: 10.1016/j.csda.2018.07.012. Epub 2018 Jul 29. PMID: 30613119; PMCID: PMC6317381.
Copy Download .nbib Format: NLM
Effectiveness of emergency physician determinations of the need for thrombolytic therapy in acute stroke.

Proceedings (Baylor University. Medical Center)

Juergens AL, Barney J, Julakanti M, Allen L, Shaver C.
PMID: 31656402
Proc (Bayl Univ Med Cent). 2019 Jul 22;32(4):485-489. doi: 10.1080/08998280.2019.1632779. eCollection 2019 Oct.

An increased emphasis on stroke care has led to a proliferation of specialized stroke teams despite relatively few trials demonstrating their efficacy. Our academic stroke center incorporated a unique setup allowing for the comparison between stroke teams and emergency...

Cite
Juergens AL, Barney J, Julakanti M, et al. Effectiveness of emergency physician determinations of the need for thrombolytic therapy in acute stroke. Proc (Bayl Univ Med Cent). 2019;32(4):485-489doi: 10.1080/08998280.2019.1632779.
Juergens, A. L., Barney, J., Julakanti, M., Allen, L., & Shaver, C. (2019). Effectiveness of emergency physician determinations of the need for thrombolytic therapy in acute stroke. Proceedings (Baylor University. Medical Center), 32(4), 485-489. https://doi.org/10.1080/08998280.2019.1632779
Juergens, Andrew L, et al. "Effectiveness of emergency physician determinations of the need for thrombolytic therapy in acute stroke." Proceedings (Baylor University. Medical Center) vol. 32,4 (2019): 485-489. doi: https://doi.org/10.1080/08998280.2019.1632779
Juergens AL, Barney J, Julakanti M, Allen L, Shaver C. Effectiveness of emergency physician determinations of the need for thrombolytic therapy in acute stroke. Proc (Bayl Univ Med Cent). 2019 Jul 22;32(4):485-489. doi: 10.1080/08998280.2019.1632779. eCollection 2019 Oct. PMID: 31656402; PMCID: PMC6793957.
Copy Download .nbib Format: NLM
Comment on "Is there a role for GPs in teaching neurology to medical students? A qualitative evaluation".

Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors

Monaghan M, Campos I.
PMID: 31104576
Educ Prim Care. 2019 Jul;30(4):257. doi: 10.1080/14739879.2019.1610079. Epub 2019 May 19.

No abstract available.

Cite
Monaghan M, Campos I. Comment on "Is there a role for GPs in teaching neurology to medical students? A qualitative evaluation". Educ Prim Care. 2019;30(4):257doi: 10.1080/14739879.2019.1610079.
Monaghan, M., & Campos, I. (2019). Comment on "Is there a role for GPs in teaching neurology to medical students? A qualitative evaluation". Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors, 30(4), 257. https://doi.org/10.1080/14739879.2019.1610079
Monaghan, Michaela, and Campos, Inga. "Comment on "Is there a role for GPs in teaching neurology to medical students? A qualitative evaluation"." Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors vol. 30,4 (2019): 257. doi: https://doi.org/10.1080/14739879.2019.1610079
Monaghan M, Campos I. Comment on "Is there a role for GPs in teaching neurology to medical students? A qualitative evaluation". Educ Prim Care. 2019 Jul;30(4):257. doi: 10.1080/14739879.2019.1610079. Epub 2019 May 19. PMID: 31104576.
Copy Download .nbib Format: NLM
Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus.

Proceedings (Baylor University. Medical Center)

Thakolwiboon S, Karukote A, Sohn G.
PMID: 31656439
Proc (Bayl Univ Med Cent). 2019 Aug 20;32(4):610-613. doi: 10.1080/08998280.2019.1647715. eCollection 2019 Oct.

Systemic lupus erythematosus (SLE) is an autoimmune disease that involves multiple organs and is generally treated by immunosuppressive agents. Acute motor-sensory axonal neuropathy (AMSAN) is a variant of Guillain-Barré syndrome. The standard therapies are intravenous immunoglobulin or plasmapheresis. An...

Cite
Thakolwiboon S, Karukote A, Sohn G. Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus. Proc (Bayl Univ Med Cent). 2019;32(4):610-613doi: 10.1080/08998280.2019.1647715.
Thakolwiboon, S., Karukote, A., & Sohn, G. (2019). Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus. Proceedings (Baylor University. Medical Center), 32(4), 610-613. https://doi.org/10.1080/08998280.2019.1647715
Thakolwiboon, Smathorn, et al. "Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus." Proceedings (Baylor University. Medical Center) vol. 32,4 (2019): 610-613. doi: https://doi.org/10.1080/08998280.2019.1647715
Thakolwiboon S, Karukote A, Sohn G. Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus. Proc (Bayl Univ Med Cent). 2019 Aug 20;32(4):610-613. doi: 10.1080/08998280.2019.1647715. eCollection 2019 Oct. PMID: 31656439; PMCID: PMC6793991.
Copy Download .nbib Format: NLM
Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection.

Journal of neurology, neurosurgery, and psychiatry

Djellaoui A, Seddik L, Cleret De Langavant L, Cattan S, Bachoud-Lévi AC, Hosseini H.
PMID: 32718920
J Neurol Neurosurg Psychiatry. 2020 Jul 27; doi: 10.1136/jnnp-2020-323923. Epub 2020 Jul 27.

No abstract available.

Cite
Djellaoui A, Seddik L, Cleret De Langavant L, et al. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection. J Neurol Neurosurg Psychiatry. 2020;doi: 10.1136/jnnp-2020-323923.
Djellaoui, A., Seddik, L., Cleret De Langavant, L., Cattan, S., Bachoud-Lévi, A. C., & Hosseini, H. (2020). Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection. Journal of neurology, neurosurgery, and psychiatry, . https://doi.org/10.1136/jnnp-2020-323923
Djellaoui, Abdenour, et al. "Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection." Journal of neurology, neurosurgery, and psychiatry vol. (2020). doi: https://doi.org/10.1136/jnnp-2020-323923
Djellaoui A, Seddik L, Cleret De Langavant L, Cattan S, Bachoud-Lévi AC, Hosseini H. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection. J Neurol Neurosurg Psychiatry. 2020 Jul 27; doi: 10.1136/jnnp-2020-323923. Epub 2020 Jul 27. PMID: 32718920.
Copy Download .nbib Format: NLM
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfaction.

European journal of hospital pharmacy : science and practice

Horta-Hernández AM, Esaclera-Izquierdo B, Yusta-Izquierdo A, Martín-Alcalde E, Blanco-Crespo M, Álvarez-Nonay A, Torralba M.
PMID: 31656616
Eur J Hosp Pharm. 2019 Sep;26(5):280-284. doi: 10.1136/ejhpharm-2018-001499. Epub 2018 Apr 28.

OBJECTIVE: To study the use of high-dose oral methylprednisolone compounded formulation and intravenous methylprednisolone for the treatment of multiple sclerosis relapses. To compare both routes of methylprednisolone administration related to cost and patient's satisfaction with the treatment.METHODS: A retrospective...

Cite
Horta-Hernández AM, Esaclera-Izquierdo B, Yusta-Izquierdo A, et al. High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfaction. Eur J Hosp Pharm. 2018;26(5):280-284doi: 10.1136/ejhpharm-2018-001499.
Horta-Hernández, A. M., Esaclera-Izquierdo, B., Yusta-Izquierdo, A., Martín-Alcalde, E., Blanco-Crespo, M., Álvarez-Nonay, A., & Torralba, M. (2019). High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfaction. European journal of hospital pharmacy : science and practice, 26(5), 280-284. https://doi.org/10.1136/ejhpharm-2018-001499
Horta-Hernández, Ana María, et al. "High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfaction." European journal of hospital pharmacy : science and practice vol. 26,5 (2019): 280-284. doi: https://doi.org/10.1136/ejhpharm-2018-001499
Horta-Hernández AM, Esaclera-Izquierdo B, Yusta-Izquierdo A, Martín-Alcalde E, Blanco-Crespo M, Álvarez-Nonay A, Torralba M. High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfaction. Eur J Hosp Pharm. 2019 Sep;26(5):280-284. doi: 10.1136/ejhpharm-2018-001499. Epub 2018 Apr 28. PMID: 31656616; PMCID: PMC6788278.
Copy Download .nbib Format: NLM
Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease.

Experimental and therapeutic medicine

Salguero MV, Al-Obaide MAI, Singh R, Siepmann T, Vasylyeva TL.
PMID: 31602221
Exp Ther Med. 2019 Nov;18(5):3461-3469. doi: 10.3892/etm.2019.7943. Epub 2019 Aug 26.

Lipopolysaccharide (LPS), a potent endotoxin present in the outer membrane of Gram-negative bacteria, causes chronic immune responses associated with inflammation. In the present study, the association between LPS and the dysbiosis of Gram-negative bacteria in the gut microbiome was...

Cite
Salguero MV, Al-Obaide MAI, Singh R, et al. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019;18(5):3461-3469doi: 10.3892/etm.2019.7943.
Salguero, M. V., Al-Obaide, M. A. I., Singh, R., Siepmann, T., & Vasylyeva, T. L. (2019). Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Experimental and therapeutic medicine, 18(5), 3461-3469. https://doi.org/10.3892/etm.2019.7943
Salguero, Maria V, et al. "Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease." Experimental and therapeutic medicine vol. 18,5 (2019): 3461-3469. doi: https://doi.org/10.3892/etm.2019.7943
Salguero MV, Al-Obaide MAI, Singh R, Siepmann T, Vasylyeva TL. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019 Nov;18(5):3461-3469. doi: 10.3892/etm.2019.7943. Epub 2019 Aug 26. PMID: 31602221; PMCID: PMC6777309.
Copy Download .nbib Format: NLM
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.

Iranian journal of neurology

Chitsaz N, Dehghani L, Safi A, Esmalian-Afyouni N, Shaygannejad V, Rezvani M, Sohrabi K, Moridi K, Moayednia M.
PMID: 32117550
Iran J Neurol. 2019 Oct 07;18(4):150-153.

No abstract available.

Cite
Chitsaz N, Dehghani L, Safi A, et al. Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Iran J Neurol. 2019;18(4):150-153
Chitsaz, N., Dehghani, L., Safi, A., Esmalian-Afyouni, N., Shaygannejad, V., Rezvani, M., Sohrabi, K., Moridi, K., & Moayednia, M. (2019). Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Iranian journal of neurology, 18(4), 150-153.
Chitsaz, Niloofar, et al. "Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica." Iranian journal of neurology vol. 18,4 (2019): 150-153.
Chitsaz N, Dehghani L, Safi A, Esmalian-Afyouni N, Shaygannejad V, Rezvani M, Sohrabi K, Moridi K, Moayednia M. Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Iran J Neurol. 2019 Oct 07;18(4):150-153. PMID: 32117550; PMCID: PMC7036045.
Copy Download .nbib Format: NLM
Ptosis following botulinum toxin injection in hemifacial spasm.

Iranian journal of neurology

Jamshidian-Tehrani M, Mehrjardi HZ, Kasaee A, Yadegari S.
PMID: 32117557
Iran J Neurol. 2019 Oct 07;18(4):184-186.

No abstract available.

Cite
Jamshidian-Tehrani M, Mehrjardi HZ, Kasaee A, et al. Ptosis following botulinum toxin injection in hemifacial spasm. Iran J Neurol. 2019;18(4):184-186
Jamshidian-Tehrani, M., Mehrjardi, H. Z., Kasaee, A., & Yadegari, S. (2019). Ptosis following botulinum toxin injection in hemifacial spasm. Iranian journal of neurology, 18(4), 184-186.
Jamshidian-Tehrani, Mansooreh, et al. "Ptosis following botulinum toxin injection in hemifacial spasm." Iranian journal of neurology vol. 18,4 (2019): 184-186.
Jamshidian-Tehrani M, Mehrjardi HZ, Kasaee A, Yadegari S. Ptosis following botulinum toxin injection in hemifacial spasm. Iran J Neurol. 2019 Oct 07;18(4):184-186. PMID: 32117557; PMCID: PMC7036047.
Copy Download .nbib Format: NLM
Correction: Transient acute-onset tetraparesis in a COVID-19 patient.

Spinal cord

Giorgianni A, Vinacci G, Agosti E, Cariddi LP, Mauri M, Baruzzi F, Versino M.
PMID: 32719526
Spinal Cord. 2020 Sep;58(9):1045. doi: 10.1038/s41393-020-0525-4.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Giorgianni A, Vinacci G, Agosti E, et al. Correction: Transient acute-onset tetraparesis in a COVID-19 patient. Spinal Cord. 2020;58(9):1045doi: 10.1038/s41393-020-0525-4.
Giorgianni, A., Vinacci, G., Agosti, E., Cariddi, L. P., Mauri, M., Baruzzi, F., & Versino, M. (2020). Correction: Transient acute-onset tetraparesis in a COVID-19 patient. Spinal cord, 58(9), 1045. https://doi.org/10.1038/s41393-020-0525-4
Giorgianni, Andrea, et al. "Correction: Transient acute-onset tetraparesis in a COVID-19 patient." Spinal cord vol. 58,9 (2020): 1045. doi: https://doi.org/10.1038/s41393-020-0525-4
Giorgianni A, Vinacci G, Agosti E, Cariddi LP, Mauri M, Baruzzi F, Versino M. Correction: Transient acute-onset tetraparesis in a COVID-19 patient. Spinal Cord. 2020 Sep;58(9):1045. doi: 10.1038/s41393-020-0525-4. PMID: 32719526; PMCID: PMC7383662.
Copy Download .nbib Format: NLM
Corrigendum to "Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas" [Biomaterials, 151(2018):38-52].

Biomaterials

Tony Liang HK, Lai XS, Wei MF, Lu SH, Wen WF, Kuo SH, Chen CM, Isaac Tseng WY, Lin FH.
PMID: 31112824
Biomaterials. 2019 Aug;212:126-127. doi: 10.1016/j.biomaterials.2019.05.015. Epub 2019 May 18.

No abstract available.

Cite
Tony Liang HK, Lai XS, Wei MF, et al. Corrigendum to "Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas" [Biomaterials, 151(2018):38-52]. Biomaterials. 2019;212:126-127doi: 10.1016/j.biomaterials.2019.05.015.
Tony Liang, H. K., Lai, X. S., Wei, M. F., Lu, S. H., Wen, W. F., Kuo, S. H., Chen, C. M., Isaac Tseng, W. Y., & Lin, F. H. (2019). Corrigendum to "Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas" [Biomaterials, 151(2018):38-52]. Biomaterials, 212126-127. https://doi.org/10.1016/j.biomaterials.2019.05.015
Tony Liang, Hsiang-Kuang, et al. "Corrigendum to "Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas" [Biomaterials, 151(2018):38-52]." Biomaterials vol. 212 (2019): 126-127. doi: https://doi.org/10.1016/j.biomaterials.2019.05.015
Tony Liang HK, Lai XS, Wei MF, Lu SH, Wen WF, Kuo SH, Chen CM, Isaac Tseng WY, Lin FH. Corrigendum to "Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas" [Biomaterials, 151(2018):38-52]. Biomaterials. 2019 Aug;212:126-127. doi: 10.1016/j.biomaterials.2019.05.015. Epub 2019 May 18. PMID: 31112824.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 126511 entries